CDKN2A and breast cancer: Our previous studies in early stage breast cancer patients who received anthracycline-containing chemotherapy did not find radiation to be a statistically significant contributor to the chemotherapy-induced increase in p16INK4a expression, and in a second larger cohort of patients not treated with chemotherapy, radiation had no effect on p16INK4a expression (29).